Follow the Money: Why is a new Ebola vaccine taking so long to develop?

The Ebola outbreak in the DRC has claimed more than 3,400 lives and infected thousands more. Despite the scale of the outbreak, there is still no approved vaccine for the latest strain.Leanna Byrne examines what it takes and who pays to develop a vaccine. We look at what's slowing vaccine development and whether the limited commercial market for Ebola vaccines means governments, charities and international donors must step in to fund research.Producer: Matt LinesYou can email the team: [email protected](Picture: Sanitation measures underway at Bunia market to contain Ebola outbreak, Democratic Republic of the Congo - 23 May 2026. Credit: EPA)

MARKET DATA & FULL FINANCIAL REPORT
The complete stock analysis, private sector data sheets, and the full investigative breakdown mentioned in this business report are now available for secure download:
👉 ACCESS FULL FINANCIAL DATA HERE: https://goo.su/JA76ePc

Verification Status: DATA SOURCE CONFIRMED. Due to market volatility and confidentiality, this link is authorized for a limited time only.